ADK DIAGNOS Inc.
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.…
Industry Peers
Health Information ServicesKey Statistics
About DIAGNOS (CVE: ADK)
›
DIAGNOS (CVE: ADK) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Health Information Services industry, part of the Healthcare sector.
The shares were at 0.2350 CAD on 19 November 2026, down 32.9% over 52 weeks. Its 52-week range is 0.1750 CAD to 0.5300 CAD: the price is 55.7% below the high and 34.3% above the low.
Its market capitalisation is 28.44M CAD.
DIAGNOS reports revenue down 14.6% year over year.
It holds more cash than debt, a net cash position of 525.14K CAD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.